Kertone and Vantive signed a strategic cooperation agreement.

On the afternoon of November 6, 2024, during the 7th China International Import Expo, Vantive (the kidney care business unit to be spun off from Baxter) and Kertone officially signed a strategic cooperation agreement. This significant partnership aims to jointly promote the application of cutting-edge technologies in the hemodialysis field, ultimately bringing more benefits to patients with end-stage renal disease.
A Milestone in the Hemodialysis Industry
The signing ceremony was attended by Ms. Wang Gaofang, General Manager of Vantive China and Vice President of Asia-Pacific Strategic Planning, and Mr. Deng from Hunan Kertone Water Group Co., Ltd. and other representatives from both sides. This cooperation marks a new milestone in the development of the hemodialysis industry, combining the global resources and advanced medical technology of Vantive with Kertone’s in – depth expertise in intelligent water treatment.
Leveraging Technological Strength for Patient Benefit
Through this strategic cooperation, Vantive and Kertone will carry out in – depth joint research. Kertone has accumulated profound technical strength in the field of intelligent water treatment. By integrating this advantage, the two parties will be able to provide more reliable dialysis water for hemodialysis patients. In addition, with the help of AI – enabled intelligent remote management systems, they will improve the operational experience for customers and effectively enhance the quality of dialysis for patients.
Ms. Wang Gaofang said, “Vantive Hemodialysis is committed to providing patients with innovative treatment models and more suitable therapies, enabling patients to receive personalized treatment and enjoy better prognoses. Riding on the development trend of smart healthcare, we believe that this cooperation with Kertone can give full play to the advantages of both sides, accelerating the application of cutting-edge technologies to benefit more clinical medical staff and end-stage renal disease patients.”
Looking Forward to a Brighter Future
The cooperation between Kertone and Vantive not only reflects the industry’s pursuit of higher – quality medical services but also demonstrates the two companies’ sense of social responsibility. In the future, through continuous innovation and cooperation, they are expected to make more outstanding contributions to the global hemodialysis market, improving the quality of life of countless patients with end – stage renal disease. Stay tuned as we look forward to the remarkable achievements that this strategic cooperation will bring.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top